StockData
Transcode Therapeutics, Inc. logo

Transcode Therapeutics, Inc. (RNAZ) income statement

RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.16−0.14 (-10.77%)

Close on Nov 20, 2026Market cap $1.17MP/E –Yield –

Transcode Therapeutics, Inc. financial ratios

See a number that looks wrong?